Baret News – Lifestyle
Author:
Sanofi Winthrop Industrie
Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP
April 7, 2026
Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease
March 31, 2026
Press Release: AAD: new results from Sanofi’s amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
March 30, 2026
Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
March 27, 2026
Press release: Availability of the Q1 2026 aide-mémoire
March 24, 2026
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
March 24, 2026
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
March 18, 2026
Press Release: Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director
March 5, 2026
Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report
March 4, 2026